Cytotoxic Flavone Analogues of Vitexicarpin, a Constituent of the Leaves of Vitex negundo

Bioassay-guided fractionation of the chloroform-soluble extract of the leaves of Vitex negundo led to the isolation of the known flavone vitexicarpin (1), which exhibited broad cytotoxicity in a human cancer cell line panel. In an attempt to increase the cytotoxic potency of 1, a series of acylation...

Full description

Saved in:
Bibliographic Details
Published inJournal of natural products (Washington, D.C.) Vol. 66; no. 6; pp. 865 - 867
Main Authors Díaz, Fredyc, Chávez, Daniel, Lee, Dongho, Mi, Qiuwen, Chai, Hee-Byung, Tan, Ghee T, Kardono, Leonardus B. S, Riswan, Soedarsono, Fairchild, Craig R, Wild, Robert, Farnsworth, Norman R, Cordell, Geoffrey A, Pezzuto, John M, Kinghorn, A. Douglas
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 01.06.2003
Amer Chemical Soc
American Society of Pharmacognosy
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bioassay-guided fractionation of the chloroform-soluble extract of the leaves of Vitex negundo led to the isolation of the known flavone vitexicarpin (1), which exhibited broad cytotoxicity in a human cancer cell line panel. In an attempt to increase the cytotoxic potency of 1, a series of acylation reactions was performed on this compound to obtain its methylated (2), acetylated (3), and six new acylated (4−9) derivatives. Compound 9, the previously unreported 5,3‘-dihexanoyloxy-3,6,7,4‘-tetramethoxyflavone, showed comparative cytotoxic potency to compound 1 and was selected for further evaluation. However, this compound was found to be inactive when evaluated in the in vivo hollow fiber assay with Lu1, KB, and LNCaP cells at the highest dose (40 mg/kg/body weight) tested, and in the in vivo P-388 leukemia model (135 mg/kg), using the ip administration route.
Bibliography:ark:/67375/TPS-DRPKRDJS-5
istex:5A96F44E3C254A005F2277F9CCD5C04830BF39BD
Medline
NIH RePORTER
ISSN:0163-3864
1520-6025
DOI:10.1021/np0300784